{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:40:08Z","timestamp":1782384008308,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1007\/s11906-004-0001-0","type":"journal-article","created":{"date-parts":[[2007,5,24]],"date-time":"2007-05-24T05:19:21Z","timestamp":1179983961000},"page":"1-4","source":"Crossref","is-referenced-by-count":35,"title":["Primary aldosteronism: A needle in a haystack or a yellow cab on fifth avenue?"],"prefix":"10.1007","volume":"6","author":[{"given":"Gian Paolo","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1_CR1","first-page":"253","volume":"116","author":"JW Conn","year":"1990","unstructured":"Conn JW: Part I. Painting background. Part II. Primary aldosteronism: a new clinical syndrome. J Lab Clin Med 1990, 116:253\u2013267.","journal-title":"J Lab Clin Med"},{"key":"1_CR2","first-page":"768","volume-title":"Hypertension: Pathophysiology and Treatment","author":"JW Conn","year":"1977","unstructured":"Conn JW: Primary aldosteronism. In Hypertension: Pathophysiology and Treatment, edn 1. Edited by Genest O, Harnet P. New York: McGraw-Hill, 1977:768\u2013780.","edition":"edn 1"},{"key":"1_CR3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1001\/jama.1964.03070160046009","volume":"190","author":"JW Conn","year":"1964","unstructured":"Conn JW: Plasma renin activity in primary aldosteronism. JAMA 1964, 190:222\u2013225.","journal-title":"JAMA"},{"key":"1_CR4","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jama.1965.03090030022005","volume":"193","author":"JW Conn","year":"1965","unstructured":"Conn JW, Cohen EL, Rovner DR, Nesbit RM: Normokalemic primary aldosteronism: a detectable cause of curable \"essential\" hypertension. JAMA 1965, 193:200\u2013206.","journal-title":"JAMA"},{"key":"1_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jama.1966.03100010077019","volume":"195","author":"JW Conn","year":"1966","unstructured":"Conn JW, Rovner DR, Cohen EL, Nesbit RM: Normokalemic primary aldosteronism: its masquerade as \"essential\" hypertension. JAMA 1966, 195:21\u201326.","journal-title":"JAMA"},{"key":"1_CR6","first-page":"883","volume":"66","author":"NM Kaplan","year":"1965","unstructured":"Kaplan NM: The incidence of primary aldosteronism in patients with \"essential\" hypertension. J Lab Clin Med 1965, 66:883\u2013884.","journal-title":"J Lab Clin Med"},{"key":"1_CR7","first-page":"1031","volume":"45","author":"NM Kaplan","year":"1966","unstructured":"Kaplan NM: The incidence of primary aldosteronism in patients with \"essential\" hypertension. J Clin Invest 1966, 45:1031\u20131032.","journal-title":"J Clin Invest"},{"key":"1_CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1001\/archinte.1969.00300120040006","volume":"123","author":"NM Kaplan","year":"1969","unstructured":"Kaplan NM: Commentary on incidence of primary aldosteronism: current estimations based on objective data. Arch Intern Med 1969, 123:152\u2013154.","journal-title":"Arch Intern Med"},{"key":"1_CR9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archinte.1969.00300120042007","volume":"123","author":"JW Conn","year":"1969","unstructured":"Conn JW: A concluding response. Arch Intern Med 1969, 123:154\u2013155.","journal-title":"Arch Intern Med"},{"key":"1_CR10","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1440-1681.1993.tb01687.x","volume":"20","author":"RD Gordon","year":"1993","unstructured":"Gordon RD, Ziesak MD, Tunny TJ, et al.: Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 1993, 20:296\u2013298.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1_CR11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00004872-199405000-00015","volume":"12","author":"GH Anderson Jr","year":"1994","unstructured":"Anderson GH Jr, Blakeman N, Streeten DH: The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients. J Hypertens 1994, 12:609\u2013615.","journal-title":"J Hypertens"},{"key":"1_CR12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1440-1681.1994.tb02519.x","volume":"21","author":"RD Gordon","year":"1994","unstructured":"Gordon RD, Stowasser M, Tunny TJ, et al.: High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 1994, 21:315\u2013318.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1_CR13","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archinte.1996.00440100086010","volume":"156","author":"S Abdelhamid","year":"1996","unstructured":"Abdelhamid S, Muller LH, Pahl S, et al.: Prevalence of adrenal and extra-adrenal Conn syndrome in hypertensive patients. Arch Intern Med 1996, 156:1190\u20131195.","journal-title":"Arch Intern Med"},{"key":"1_CR14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1445-5994.1996.tb00600.x","volume":"26","author":"MA Brown","year":"1996","unstructured":"Brown MA, Cramp HA, Zammit VC, Whitworth JA: Primary hyperaldosteronism: a missed diagnosis in \u2018essential hypertensives\u2019? Aust N Z J Med 1996, 26:533\u2013538.","journal-title":"Aust N Z J Med"},{"key":"1_CR15","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1365-2265.1998.00608.x","volume":"49","author":"GP Rossi","year":"1998","unstructured":"Rossi GP, Rossi E, Pavan E, et al.: Screening for primary aldosteronism with a logistic multivariate discriminant analysis. Clin Endocrinol Oxf 1998, 49:713\u2013723.","journal-title":"Clin Endocrinol Oxf"},{"key":"1_CR16","first-page":"800","volume":"127","author":"L Mosso","year":"1999","unstructured":"Mosso L, Fardella C, Montero J, et al.: [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension]. Rev Med Chil 1999, 127:800\u2013806.","journal-title":"Rev Med Chil"},{"key":"1_CR17","first-page":"394","volume":"90","author":"BL Rayner","year":"2000","unstructured":"Rayner BL, Opie LH, Davidson JS: The aldosterone\/renin ratio as a screening test for primary aldosteronism. S Afr Med J 2000, 90:394\u2013400.","journal-title":"S Afr Med J"},{"key":"1_CR18","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, et al.: Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 2000, 85:2854\u20132859.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR19","first-page":"1037","volume":"93","author":"T Denolle","year":"2000","unstructured":"Denolle T, Hanon O, Mounier-Vehier C, et al.: [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?]. Arch Mal Coeur Vaiss 2000, 93:1037\u20131039.","journal-title":"Arch Mal Coeur Vaiss"},{"key":"1_CR20","first-page":"955","volume":"128","author":"P Cortes","year":"2000","unstructured":"Cortes P, Fardella C, Oestreicher E, et al.: [Excess of mineralocorticoids in essential hypertension: clinicaldiagnostic approach]. Rev Med Chil 2000, 128:955\u2013961.","journal-title":"Rev Med Chil"},{"issue":"Suppl 1","key":"1_CR21","doi-asserted-by":"crossref","first-page":"83s","DOI":"10.1016\/S0753-3322(00)80019-0","volume":"54","author":"T Nishikawa","year":"2000","unstructured":"Nishikawa T, Omura M: Clinical characteristics of primary aldosteronism: its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed Pharmacother 2000, 54(Suppl 1):83s-85s.","journal-title":"Biomed Pharmacother"},{"key":"1_CR22","first-page":"1863","volume":"85","author":"CE Fardella","year":"2000","unstructured":"Fardella CE, Mosso L, Gomez-Sanchez C, et al.: Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 2000, 85:1863\u20131867.","journal-title":"J Clin Endocrinol Metab"},{"key":"1_CR23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/sj.jhh.1001013","volume":"14","author":"PO Lim","year":"2000","unstructured":"Lim PO, Dow E, Brennan G, et al.: High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum Hypertens 2000, 14:311\u2013315.","journal-title":"J Hum Hypertens"},{"key":"1_CR24","first-page":"594","volume":"91","author":"BL Rayner","year":"2001","unstructured":"Rayner BL, Myers JE, Opie LH, et al.: Screening for primary aldosteronism: normal ranges for aldosterone and renin in three South African population groups. S Afr Med J 2001, 91:594\u2013599.","journal-title":"S Afr Med J"},{"key":"1_CR25","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, et al.: Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002, 40:892\u2013896.","journal-title":"Hypertension"},{"key":"1_CR26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0895-7061(02)02969-2","volume":"15","author":"E Rossi","year":"2002","unstructured":"Rossi E, Regolisti G, Negro A, et al.: High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 2002, 15:896\u2013902.","journal-title":"Am J Hypertens"},{"key":"1_CR27","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1093\/clinchem\/48.11.1919","volume":"48","author":"GL Schwartz","year":"2002","unstructured":"Schwartz GL, Chapman AB, Boerwinkle E, et al.: Screening for primary aldosteronism: implications of an increased plasma aldosterone\/renin ratio. Clin Chem 2002, 48:1919\u20131923.","journal-title":"Clin Chem"},{"key":"1_CR28","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/00325481.1986.11699456","volume":"80","author":"EL Bravo","year":"1986","unstructured":"Bravo EL: Secondary hypertension: a streamlined approach to diagnosis. Postgrad Med 1986, 80:139\u2013151.","journal-title":"Postgrad Med"},{"key":"1_CR29","first-page":"1801","volume":"13","author":"JM Halimi","year":"1995","unstructured":"Halimi JM, Mimran A: Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens 1995, 13:1801\u20131802.","journal-title":"J Hypertens"},{"key":"1_CR30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0272-6386(99)70298-2","volume":"33","author":"M Nishimura","year":"1999","unstructured":"Nishimura M, Uzu T, Fujii T, et al.: Cardiovascular complications in patients with primary aldosteronism. Am J Kidney Dis 1999, 33:261\u2013266.","journal-title":"Am J Kidney Dis"},{"key":"1_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","volume":"18","author":"R Takeda","year":"1995","unstructured":"Takeda R, Matsubara T, Miyamori I, et al.: Vascular complications in patients with aldosterone-producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan. J Endocrinol Invest 1995, 18:370\u2013373.","journal-title":"J Endocrinol Invest"},{"key":"1_CR32","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/0002-9149(88)90264-0","volume":"62","author":"T Suzuki","year":"1988","unstructured":"Suzuki T, Abe H, Nagata S, et al.: Left ventricular structural characteristics in unilateral renovascular hypertension and primary aldosteronism. Am J Cardiol 1988, 62:1224\u20131227.","journal-title":"Am J Cardiol"},{"key":"1_CR33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/ajh\/6.11.907","volume":"6","author":"T Denolle","year":"1993","unstructured":"Denolle T, Chatellier G, Julien J, et al.: Left ventricular mass and geometry before and after etiologic treatment in renovascular hypertension, aldosterone-producing adenoma, and pheochromocytoma. Am J Hypertens 1993, 6:907\u2013913.","journal-title":"Am J Hypertens"},{"key":"1_CR34","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1161\/01.HYP.27.5.1039","volume":"27","author":"GP Rossi","year":"1996","unstructured":"Rossi GP, Sacchetto A, Visentin PA, et al.: Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 1996, 27:1039\u20131045.","journal-title":"Hypertension"},{"key":"1_CR35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/01.HYP.29.3.723","volume":"29","author":"Y Shigematsu","year":"1997","unstructured":"Shigematsu Y, Hamada M, Okayama H, et al.: Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997, 29:723\u2013727.","journal-title":"Hypertension"},{"key":"1_CR36","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1161\/01.CIR.95.6.1471","volume":"95","author":"GP Rossi","year":"1997","unstructured":"Rossi GP, Sacchetto A, Pavan E, et al.: Remodeling of the left ventricle in primary aldosteronism due to Conn\u2019s adenoma. Circulation 1997, 95:1471\u20131478.","journal-title":"Circulation"},{"key":"1_CR37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/ajh\/6.1.8","volume":"6","author":"G Rossi","year":"1993","unstructured":"Rossi G, Rossi A, Zanin L, et al.: Prevalence of extracranial carotid artery lesions at duplex in primary aldosteronism. Am J Hypertens 1993, 6:8\u201314.","journal-title":"Am J Hypertens"},{"key":"1_CR38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.HYP.31.1.335","volume":"31","author":"D Rizzoni","year":"1998","unstructured":"Rizzoni D, Porteri E, Castellano M, et al.: Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension 1998, 31:335\u2013341.","journal-title":"Hypertension"},{"key":"1_CR39","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0735-1097(98)00322-2","volume":"32","author":"D Rizzoni","year":"1998","unstructured":"Rizzoni D, Muiesan ML, Porteri E, et al.: Relations between cardiac and vascular structure in patients with primary and secondary hypertension. J Am Coll Cardiol 1998, 32:985\u2013992.","journal-title":"J Am Coll Cardiol"},{"key":"1_CR40","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3109\/08037059209077510","volume":"1","author":"SE Campbell","year":"1992","unstructured":"Campbell SE, Diaz-Arias AA, Weber KT: Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Press 1992, 1:149\u2013156.","journal-title":"Blood Press"},{"key":"1_CR41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","volume":"40","author":"GP Rossi","year":"2002","unstructured":"Rossi GP, Di Bello V, Ganzaroli C, et al.: Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002, 40:23\u201327.","journal-title":"Hypertension"},{"key":"1_CR42","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","volume":"41","author":"M Kozakova","year":"2003","unstructured":"Kozakova M, Buralli S, Palombo C, et al.: Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 2003, 41:230\u2013236.","journal-title":"Hypertension"},{"issue":"Suppl8","key":"1_CR43","first-page":"S147","volume":"19","author":"GP Rossi","year":"1997","unstructured":"Rossi GP, Sacchetto A, Pavan E, et al.: Left ventricular systolic function in primary aldosteronism and hypertension. J Hypertens 1997, 19 (Suppl8):S147-S151.","journal-title":"J Hypertens"},{"key":"1_CR44","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"CG Brilla","year":"1990","unstructured":"Brilla CG, Pick R, Tan LB, et al.: Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990, 67:1355\u20131364.","journal-title":"Circ Res"},{"key":"1_CR45","first-page":"127","volume":"20","author":"CG Brilla","year":"1995","unstructured":"Brilla CG, Maisch B, Rupp H, et al.: Pharmacological modulation of cardiac fibroblast function. Herz 1995, 20:127\u2013134.","journal-title":"Herz"},{"key":"1_CR46","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al.: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999, 341:709\u2013717.","journal-title":"N Engl J Med"},{"key":"1_CR47","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F, et al.: Eplerenone: a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003, 348:1309\u20131321.","journal-title":"N Engl J Med"},{"key":"1_CR48","first-page":"357","volume":"7","author":"GP Rossi","year":"1993","unstructured":"Rossi GP, Chiesura Corona M, et al.: Imaging of aldosteronesecreting adenomas: a prospective comparison of computed tomography and magnetic resonance imaging in 27 patients with suspected primary aldosteronism. J HumHypertens 1993, 7:357\u2013363.","journal-title":"J HumHypertens"},{"key":"1_CR49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-123-1-199507010-00013","volume":"123","author":"GP Rossi","year":"1995","unstructured":"Rossi GP, Chiesura-Corona M, Gregianin M: Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med 1995, 123:73\u201374.","journal-title":"Ann Intern Med"},{"key":"1_CR50","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-76-6-391","volume":"76","author":"BA Scoggins","year":"1972","unstructured":"Scoggins BA, Oddie CJ, Hare WSC, Coghlan JP: Preoperative lateralisation of aldosterone-producing tumours in primary aldosteronism. Ann Intern Med 1972, 76:891\u2013897.","journal-title":"Ann Intern Med"},{"key":"1_CR51","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1210\/jcem.86.3.7287","volume":"86","author":"GP Rossi","year":"2001","unstructured":"Rossi GP, Sacchetto A, Chiesura-Corona M, et al.: Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: results in 104 consecutive cases. J Clin Endocrinol Metab 2001, 86:1083\u20131090.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-004-0001-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-004-0001-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-004-0001-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T08:22:42Z","timestamp":1587543762000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-004-0001-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["1"],"URL":"https:\/\/doi.org\/10.1007\/s11906-004-0001-0","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}